Conditions: Asthma; Chronic Obstructive Pulmonary DiseaseInterventions: Drug: Fluticasone furoate (200 mcg)/GW642444 (25mcg) combination; Drug: Fluticasone furoate (400 mcg)/GW642444 (50mcg) combination; Drug: Placebo Inhaler; Drug: Moxifloxacin 400mg; Drug: Moxifloxacin placeboSponsor: GlaxoSmithKlineRecruiting – verified September 2010 View full post on ClinicalTrials.gov: “Asthma” |…